BioXcel Therapeutics inventory hits 52-week low at $0.35 By Investing.com
In a difficult market setting, BioXcel Therapeutics Inc (NASDAQ:). inventory has reached…
Viridian Therapeutics to Webcast Veligrotug Part 3 THRIVE-2 Topline Outcomes on December 16, 2024 By Investing.com
- THRIVE-2 world section 3 medical trial evaluated efficacy and security of…
Beam Therapeutics Pronounces New Knowledge from BEACON Section 1/2 Medical Trial of BEAM-101 in Sickle Cell Illness at American Society of Hematology (ASH) Annual Assembly By Investing.com
All Seven Sufferers Handled with BEAM-101 Achieved Hemoglobin F (HbF) Induction of…
Janux Therapeutics CEO sells $1 million in inventory By Investing.com
David Alan Campbell, President and CEO of Janux Therapeutics, Inc. (NASDAQ:JANX), lately…
Rakovina Therapeutics Proclaims Personal Placement Providing By Investing.com
VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc.…
Roche to amass US agency Poseida Therapeutics in $1.5 billion deal By Reuters
ZURICH (Reuters) -Switzerland's Roche will purchase U.S. biopharma agency Poseida Therapeutics in…
Carisma Therapeutics Presents Promising New Preclinical Knowledge on Engineered Macrophages for the Remedy of Liver Fibrosis at AASLD The Liver Assembly ® 2024 By Investing.com
New preclinical outcomes help the anti-fibrotic potential of engineered macrophages in a…
Omega Therapeutics inventory hits 52-week low at $0.89 By Investing.com
In a difficult yr for Omega Therapeutics, the biotechnology agency's inventory has…
EcoR1 Capital sells $8.4 million in Tango Therapeutics inventory By Investing.com
SAN FRANCISCO—EcoR1 Capital, LLC, a big shareholder in Tango Therapeutics, Inc. (NASDAQ:TNGX),…
United Therapeutics shares rated Impartial by Ladenburg, goal lifted on Tyvaso gross sales energy By Investing.com
On Thursday, Ladenburg Thalmann up to date its monetary outlook on United…
